These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 38474799)

  • 1. The Role of Probiotics in the Prevention of
    Dudzicz-Gojowy S; Więcek A; Adamczak M
    Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474799
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Dudzicz S; Wiecek A; Adamczak M
    J Clin Med; 2021 Jan; 10(2):. PubMed ID: 33430465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotics for Prevention and Treatment of Clostridium difficile Infection.
    Valdés-Varela L; Gueimonde M; Ruas-Madiedo P
    Adv Exp Med Biol; 2024; 1435():101-116. PubMed ID: 38175473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A High-Carbohydrate Diet Prolongs Dysbiosis and Clostridioides difficile Carriage and Increases Delayed Mortality in a Hamster Model of Infection.
    Bhute SS; Mefferd CC; Phan JR; Ahmed M; Fox-King AE; Alarcia S; Villarama JV; Abel-Santos E; Hedlund BP
    Microbiol Spectr; 2022 Aug; 10(4):e0180421. PubMed ID: 35708337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotics: insights and new opportunities for
    Pal R; Athamneh AIM; Deshpande R; Ramirez JAR; Adu KT; Muthuirulan P; Pawar S; Biazzo M; Apidianakis Y; Sundekilde UK; de la Fuente-Nunez C; Martens MG; Tegos GP; Seleem MN
    Crit Rev Microbiol; 2023 May; 49(3):414-434. PubMed ID: 35574602
    [No Abstract]   [Full Text] [Related]  

  • 6. A Multicenter Evaluation of Probiotic Use for the Primary Prevention of Clostridioides difficile Infection.
    Heil EL; Harris AD; Brown C; Seung H; Thom KA; von Rosenvinge E; Sorongon S; Pineles L; Goodman KE; Leekha S
    Clin Infect Dis; 2021 Oct; 73(8):1330-1337. PubMed ID: 33972996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-antibiotic therapy for
    Yang J; Yang H
    Crit Rev Clin Lab Sci; 2019 Nov; 56(7):493-509. PubMed ID: 31411909
    [No Abstract]   [Full Text] [Related]  

  • 8. Probiotics for primary prevention of
    Fajnzylber J; Patterson W; Deshpande A
    Curr Med Res Opin; 2023 Jun; 39(6):889-891. PubMed ID: 37078551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridioides difficile Infection in Chronic Kidney Disease/End-Stage Renal Disease.
    Ramesh MS; Yee J
    Adv Chronic Kidney Dis; 2019 Jan; 26(1):30-34. PubMed ID: 30876614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridioides difficile Infection in Patients with Chronic Kidney Disease: A Systematic Review.
    Mihaescu A; Augustine AM; Khokhar HT; Zafran M; Masood SSME; Gilca-Blanariu GE; Covic A; Nistor I
    Biomed Res Int; 2021; 2021():5466656. PubMed ID: 34557546
    [No Abstract]   [Full Text] [Related]  

  • 11. Clostridium Difficile Infection in the Nephrology Ward.
    Dudzicz S; Adamczak M; Więcek A
    Kidney Blood Press Res; 2017; 42(5):844-852. PubMed ID: 29161712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering probiotics to inhibit Clostridioides difficile infection by dynamic regulation of intestinal metabolism.
    Koh E; Hwang IY; Lee HL; De Sotto R; Lee JWJ; Lee YS; March JC; Chang MW
    Nat Commun; 2022 Jul; 13(1):3834. PubMed ID: 35787625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotics for Prevention and Treatment of Clostridium difficile Infection.
    Valdés-Varela L; Gueimonde M; Ruas-Madiedo P
    Adv Exp Med Biol; 2018; 1050():161-176. PubMed ID: 29383669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure.
    Lee CH; Chai J; Hammond K; Jeon SR; Patel Y; Goldeh C; Kim P
    Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1731-1735. PubMed ID: 31165961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlating Antibiotic-Induced Dysbiosis to
    Moore JH; Salahi A; Honrado C; Warburton C; Tate S; Warren CA; Swami NS
    ACS Infect Dis; 2023 Oct; 9(10):1878-1888. PubMed ID: 37756389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ridinilazole: a novel, narrow-spectrum antimicrobial agent targeting Clostridium (Clostridioides) difficile.
    Collins DA; Riley TV
    Lett Appl Microbiol; 2022 Sep; 75(3):526-536. PubMed ID: 35119124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
    Khanna S; Assi M; Lee C; Yoho D; Louie T; Knapple W; Aguilar H; Garcia-Diaz J; Wang GP; Berry SM; Marion J; Su X; Braun T; Bancke L; Feuerstadt P
    Drugs; 2022 Oct; 82(15):1527-1538. PubMed ID: 36287379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Saccharomyces boulardii Primary Prevention on Risk of Hospital-onset Clostridioides difficile Infection in Hospitalized Patients Administered Antibiotics Frequently Associated With C. difficile Infection.
    Wombwell E; Patterson ME; Bransteitter B; Gillen LR
    Clin Infect Dis; 2021 Nov; 73(9):e2512-e2518. PubMed ID: 32575126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of Clinical Severity With Stool Microbiome Changes in Clostridioides difficile Infection.
    Castañeda-Mogollón D; Doolan CP; Toppings NB; Amarasekara R; Tran TA; Pillai DR
    Arch Pathol Lab Med; 2023 Jul; 147(7):774-785. PubMed ID: 36308712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on Treatment of Clostridioides difficile Infection.
    Cho JM; Pardi DS; Khanna S
    Mayo Clin Proc; 2020 Apr; 95(4):758-769. PubMed ID: 32247350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.